Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.52−0.09 (-5.30%)
Close on Nov 17, 2026Market cap $24.93MP/E –Yield –
Cellyan Biotechnology gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2026 it was 10.3%, against 11.9% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | 10.3% | −1.6 |
| FY2025 | Mar 31, 2025 | 11.9% | −9.4 |
| FY2024 | Mar 31, 2024 | 21.3% | −0.5 |
| FY2023 | Mar 31, 2023 | 21.8% | – |
See a number that looks wrong?